Legal cannabis has changed the workplace—but it hasn’t eliminated drug testing. In New Jersey, employers still retain important rights to protect workplace safety, enforce drug-free policies, and conduct drug testing using urine and saliva drug tests—when it’s done correctly.
As we move through 2026, confusion remains common. Can employers still test for cannabis? Can they take action based on results? And when does saliva testing make more sense than urine?
This guide breaks down what New Jersey law actually allows, when employers can still test, and how to stay compliant while protecting your workforce.
A Quick Overview of New Jersey Cannabis Law
New Jersey legalized adult-use cannabis under the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA). While the law protects employees from being disciplined solely for lawful, off-duty cannabis use, it does not prohibit workplace drug testing.
In plain English:
Cannabis is legal—but impairment at work is not.
Employers still have a legal obligation to maintain a safe workplace, particularly in safety-sensitive roles.
Can New Jersey Employers Still Drug Test?
Yes. New Jersey employers may still conduct drug testing, including:
-
Pre-employment testing
-
Random testing
-
Post-accident testing
-
Reasonable suspicion testing
-
Return-to-duty testing
This includes the use of urine drug tests and saliva (oral fluid) drug tests.
What changed is how test results can be used, especially when cannabis is involved.
When Urine and Saliva Drug Tests Are Still Allowed
1. Testing for Non-Cannabis Drugs
Employers may continue to test for all other controlled substances (opioids, amphetamines, cocaine, benzodiazepines, fentanyl, etc.) using urine or saliva tests—with no special restrictions.
If an employee tests positive for a non-cannabis drug, employers may take action in accordance with company policy.
2. Reasonable Suspicion of Impairment
New Jersey law allows employers to test when there is reasonable suspicion of impairment at work, including suspected cannabis impairment.
Reasonable suspicion may be based on:
-
Observable behavior
-
Physical signs
-
Speech or coordination issues
-
Involvement in a workplace incident or accident
In these cases, saliva drug testing is increasingly favored in 2026 because it helps identify recent use, not historical exposure.
3. Post-Accident and Safety-Related Testing
Employers may conduct drug testing following:
-
Workplace accidents
-
Near-miss incidents
-
Safety violations
This applies even in a cannabis-legal state, particularly for roles involving machinery, driving, healthcare, or public safety.
4. Pre-Employment Testing (With Limits)
New Jersey employers may still conduct pre-employment drug testing, but cannot rescind an offer solely due to a positive cannabis result unless impairment or another lawful basis is documented.
Testing itself is allowed—the restriction is on adverse action, not screening.
Urine vs. Saliva Drug Tests Under New Jersey Law
Urine Drug Testing
Urine tests remain widely used and legally permitted. However, they detect cannabis metabolites that can remain in the body for days or weeks.
In New Jersey, this creates risk if urine results are used alone to make employment decisions related to cannabis.
Saliva (Oral Fluid) Drug Testing
Saliva testing is gaining traction in 2026 because it:
-
Detects more recent use
-
Is harder to tamper with
-
Allows observed collection
-
Aligns better with impairment-based decision-making
For New Jersey employers focused on on-the-job impairment, saliva testing is often the safer compliance choice.
What About the WIRE Requirement?
New Jersey law references the use of a Workplace Impairment Recognition Expert (WIRE) to support cannabis-related disciplinary decisions. However, implementation has been delayed and remains inconsistent statewide.
As of 2026:
-
Employers should document observable signs of impairment
-
Drug test results should be used as supporting evidence, not the sole factor
-
Policies must be applied consistently
This is another reason employers are pairing observations + saliva testing rather than relying on urine results alone.
Best Practices for New Jersey Employers in 2026
To stay compliant while protecting your workplace:
-
Continue drug testing, but update policies
-
Train supervisors on reasonable suspicion documentation
-
Use saliva tests when impairment timing matters
-
Avoid adverse action based solely on cannabis metabolites
-
Apply policies consistently across roles and locations
-
Consult legal counsel for safety-sensitive positions
Employers who modernize their approach can reduce legal risk while maintaining safety.
How DrugScreens.com Supports New Jersey Employers
DrugScreens.com provides CLIA-waived, FDA-cleared urine and saliva drug test kits designed for modern compliance challenges, including cannabis-legal states like New Jersey.
Our solutions help employers:
-
Screen efficiently
-
Detect recent use when appropriate
-
Reduce tampering risk
-
Support defensible, policy-aligned decisions
The Bottom Line
New Jersey’s cannabis laws changed the rules—but they didn’t remove employer rights.
In 2026, employers can still use urine and saliva drug tests when testing is tied to safety, impairment, or legitimate workplace needs. The key is using the right test, in the right situation, with the right documentation.
Smart employers aren’t abandoning drug testing—they’re updating it.
Â
